Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFM 99-06: MPT vs MP vs MEL100 in Elderly Myeloma
NCT00367185Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by CHU de Lille. Started May 2000; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00367185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367185.